Literature DB >> 9032960

Are IgG antibody avidity assays useful in the diagnosis of infectious diseases? A review.

J Gutiérrez1, C Maroto.   

Abstract

The reliability of tests for the identification of low avidity specific IgG in infectious diseases was investigated. The IgG antibody avidity assays were proposed in order to examine the probable aetiology, the accurate moment of primary infection and to distinguish between reactivation, reinfection or primary infection, in cases with false positive IgM or without specific IgM response. Such assays improve the usual serological techniques.

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 9032960

Source DB:  PubMed          Journal:  Microbios        ISSN： 0026-2633


  9 in total

1.  Utility of IgM/IgG ratio and IgG avidity for distinguishing primary and secondary dengue virus infections using sera collected more than 30 days after disease onset.

Authors:  Harry E Prince; Cindy Yeh; Mary Lapé-Nixon
Journal:  Clin Vaccine Immunol       Date:  2011-08-31

2.  Evaluation of indirect enzyme-linked immunosorbent assays and IgG avidity assays using a protein A-peroxidase conjugate for serological distinction between Brucella abortus S19-vaccinated and -infected cows.

Authors:  Ana C A M Pajuaba; Deise A O Silva; José R Mineo
Journal:  Clin Vaccine Immunol       Date:  2010-02-10

3.  Molecular markers in acute and chronic phases of human toxoplasmosis: determination of immunoglobulin G avidity by Western blotting.

Authors:  P T Marcolino; D A Silva; P G Leser; M E Camargo; J R Mineo
Journal:  Clin Diagn Lab Immunol       Date:  2000-05

Review 4.  Human Parvoviruses.

Authors:  Jianming Qiu; Maria Söderlund-Venermo; Neal S Young
Journal:  Clin Microbiol Rev       Date:  2017-01       Impact factor: 26.132

5.  Quantification of antibody avidities and accurate detection of SARS-CoV-2 antibodies in serum and saliva on plasmonic substrates.

Authors:  Tiancheng Liu; Jessica Hsiung; Su Zhao; Jessica Kost; Deepika Sreedhar; Carl V Hanson; Kjerstie Olson; Douglas Keare; Shin Ting Chang; Kevin P Bliden; Paul A Gurbel; Udaya S Tantry; John Roche; Cynthia Press; John Boggs; Jorge P Rodriguez-Soto; Jose G Montoya; Meijie Tang; Hongjie Dai
Journal:  Nat Biomed Eng       Date:  2020-10-29       Impact factor: 25.671

6.  The use of peptide arrays for the characterization of monospecific antibody repertoires from polyclonal sera of psychiatric patients suspected of infection by Borna Disease Virus.

Authors:  Martin Schwemmle; Christian Billich
Journal:  Mol Divers       Date:  2004       Impact factor: 2.943

7.  Activation of SARS-CoV-2 neutralizing antibody is slower than elevation of spike-specific IgG, IgM, and nucleocapsid-specific IgG antibodies.

Authors:  Maika Takahashi; Tomohiko Ai; Konomi Sinozuka; Yuna Baba; Gene Igawa; Shuko Nojiri; Takamasa Yamamoto; Maiko Yuri; Satomi Takei; Kaori Saito; Yuki Horiuchi; Takayuki Kanno; Minoru Tobiume; Abdullah Khasawneh; Faith Jessica Paran; Makoto Hiki; Mitsuru Wakita; Takashi Miida; Tadaki Suzuki; Atsushi Okuzawa; Kazuhisa Takahashi; Toshio Naito; Yoko Tabe
Journal:  Sci Rep       Date:  2022-09-01       Impact factor: 4.996

8.  Low quantity and quality of anti-spike humoral response is linked to CD4 T-cell apoptosis in COVID-19 patients.

Authors:  Sonia André; Marne Azarias da Silva; Ricardo Silvestre; Pierre Corbeau; Fabrizio Mammano; Jérôme Estaquier; Morgane Picard; Aurélie Alleaume-Buteau; Lucy Kundura; Renaud Cezar; Calaiselvy Soudaramourty; Santa Cruz André; Ana Mendes-Frias; Alexandre Carvalho; Carlos Capela; Jorge Pedrosa; António Gil Castro; Paul Loubet; Albert Sotto; Laurent Muller; Jean-Yves Lefrant; Claire Roger; Pierre-Géraud Claret; Sandra Duvnjak; Tu-Anh Tran; Ouafa Zghidi-Abouzid; Pierre Nioche
Journal:  Cell Death Dis       Date:  2022-08-27       Impact factor: 9.685

9.  Avidity of IgG to SARS-CoV-2 RBD as a Prognostic Factor for the Severity of COVID-19 Reinfection.

Authors:  Victor Manuylov; Olga Burgasova; Olga Borisova; Svetlana Smetanina; Daria Vasina; Igor Grigoriev; Alexandra Kudryashova; Maria Semashko; Bogdan Cherepovich; Olga Kharchenko; Denis Kleymenov; Elena Mazunina; Artem Tkachuk; Vladimir Gushchin
Journal:  Viruses       Date:  2022-03-16       Impact factor: 5.048
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.